SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

JP Morgan Downgrades Alnylam Pharmaceuticals to Neutral, Raises Price Target of $137

JP Morgan analyst Anupam Rama downgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) from Overweight to Neutral and raises the price target from $133 to $137.

Benzinga · 05/07/2020 10:11

JP Morgan analyst Anupam Rama downgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) from Overweight to Neutral and raises the price target from $133 to $137.